全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

姜黄及其活性成分在结直肠癌治疗中的研究进展
Research Progress of Turmeric and Its Active Components in the Treatment of Colorectal Cancer

DOI: 10.12677/tcm.2025.144269, PP. 1823-1830

Keywords: 姜黄,姜黄素,结直肠癌,信号通路,药食同源
Turmeric
, Curcumin, Colorectal Cancer, Signaling Pathways, Food-Medicine Homology

Full-Text   Cite this paper   Add to My Lib

Abstract:

结直肠癌(Colorectal Cancer, CRC)是全球范围内常见的恶性肿瘤之一,其发病率和死亡率呈上升趋势。姜黄(Curcuma longa)及其主要活性成分姜黄素(Curcumin)具有抗炎、抗氧化、抗增殖及促凋亡等多种生物活性,近年来在结直肠癌防治领域受到广泛关注。本文综合近年来的相关文献,详细阐述了结直肠癌的流行病学特点、致病机制、关键分子靶点,以及姜黄素调控的细胞信号通路。同时,系统总结了姜黄素单体、姜黄复方及其纳米递送系统在结直肠癌治疗中的研究进展,探讨了姜黄素与其他化疗药物协同增效及降低耐药性的潜力,为姜黄及其活性成分在结直肠癌临床治疗中的应用提供全面的理论依据和新的策略思路。
Colorectal cancer (CRC) is one of the most common malignancies worldwide, with increasing incidence and mortality rates. Turmeric (Curcuma longa) and its primary active component, curcumin, exhibit diverse biological activities, including anti-inflammatory, antioxidant, anti-proliferative, and pro-apoptotic effects. In recent years, they have garnered significant attention in CRC prevention and treatment. This review synthesizes recent literature to elaborate on the epidemiological characteristics, pathogenic mechanisms, and key molecular targets of CRC, as well as the cellular signaling pathways regulated by curcumin. Additionally, it systematically summarizes the research progress of curcumin monomers, turmeric compound formulas, and nanodelivery systems in CRC treatment, explores the potential of curcumin to synergize with chemotherapeutic agents and reduce drug resistance, and provides comprehensive theoretical evidence and novel strategic insights for the clinical application of turmeric and its active components in CRC therapy.

References

[1]  Ionescu, V.A., Gheorghe, G., Bacalbasa, N., Chiotoroiu, A.L. and Diaconu, C. (2023) Colorectal Cancer: From Risk Factors to Oncogenesis. Medicina, 59, Article 1646.
https://doi.org/10.3390/medicina59091646
[2]  宋莉平, 王宇. 姜黄素药理作用及机制研究进展[J]. 中国医药导报, 2020, 17(20): 29-33.
[3]  Kocaadam, B. and Şanlier, N. (2015) Curcumin, an Active Component of Turmeric (Curcuma longa), and Its Effects on Health. Critical Reviews in Food Science and Nutrition, 57, 2889-2895.
https://doi.org/10.1080/10408398.2015.1077195
[4]  阎晗, 黄珊. 姜黄素对人结直肠癌SW-620细胞抗肿瘤效果的研究[J]. 天津医科大学学报, 2024, 30(6): 479-484.
[5]  Huang, D., Sun, W., Zhou, Y., Li, P., Chen, F., Chen, H., et al. (2018) Mutations of Key Driver Genes in Colorectal Cancer Progression and Metastasis. Cancer and Metastasis Reviews, 37, 173-187.
https://doi.org/10.1007/s10555-017-9726-5
[6]  Modest, D.P., Pant, S. and Sartore-Bianchi, A. (2019) Treatment Sequencing in Metastatic Colorectal Cancer. European Journal of Cancer, 109, 70-83.
https://doi.org/10.1016/j.ejca.2018.12.019
[7]  王颖, 张璐璐. 结直肠癌患者肠道菌群失调与免疫球蛋白及炎症因子表达水平的相关性分析[J]. 系统医学, 2024, 9(9): 56-60.
[8]  Auyeung, K.K. and Ko, J.K. (2017) Angiogenesis and Oxidative Stress in Metastatic Tumor Progression: Pathogenesis and Novel Therapeutic Approach of Colon Cancer. Current Pharmaceutical Design, 23, 3952-3961.
https://doi.org/10.2174/1381612823666170228124105
[9]  Zhan, T., Rindtorff, N. and Boutros, M. (2016) Wnt Signaling in Cancer. Oncogene, 36, 1461-1473.
https://doi.org/10.1038/onc.2016.304
[10]  Tang, M., Xu, H., Huang, H., Kuang, H., Wang, C., Li, Q., et al. (2022) Metabolism‐Based Molecular Subtyping Endows Effective Ketogenic Therapy in P53‐Mutant Colon Cancer. Advanced Science, 9, e2201992.
https://doi.org/10.1002/advs.202201992
[11]  曹国栋, 曹芳. PI3K/AKT/mTOR信号通路及相关表观遗传调控机制在结直肠癌中的研究进展[J]. 癌变.畸变.突变, 2023, 35(2): 148-153.
[12]  黎春海, 闫珺. 具核梭杆菌在结直肠癌诊断中的价值研究进展[J]. 中国医药导报, 2024, 21(33): 49-55.
[13]  王万昌, 许顺江. 肠道菌群与结直肠癌相关性研究进展[J]. 安徽医科大学学报, 2024, 59(7): 1285-1289.
[14]  Razavi, B.M., Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H. (2021) A Review of Therapeutic Potentials of Turmeric (Curcuma longa) and Its Active Constituent, Curcumin, on Inflammatory Disorders, Pain, and Their Related Patents. Phytotherapy Research, 35, 6489-6513.
https://doi.org/10.1002/ptr.7224
[15]  盛小红, 王利明, 赵鑫, 等. 姜黄素对葡萄膜黑色素瘤细胞恶性生物学行为及Wnt/β-catenin通路的抑制作用[J]. 中华实验眼科杂志, 2024, 42(1): 29-37.
[16]  王馨, 陈姝彤, 侯宗昊, 等. 姜黄素对前列腺癌细胞增殖、侵袭及细胞周期的影响[J]. 北华大学学报(自然科学版), 2024, 25(6): 770-775.
[17]  田德增, 朱辉, 梁永杰. 姜黄素对肺腺癌A549细胞凋亡的影响及其机制[J]. 中国临床药学杂志, 2006, 15(1): 8-10.
[18]  李祺福, 郑燕彬, 杨海波, 等. 姜黄素诱导人成骨肉瘤MG-63细胞凋亡过程中核基质蛋白表达的变化[J]. 分子细胞生物学报, 2008, 41(6): 473-481.
[19]  Gao, C., Zhou, Y., Chen, Z., Li, H., Xiao, Y., Hao, W., et al. (2022) Turmeric-Derived Nanovesicles as Novel Nanobiologics for Targeted Therapy of Ulcerative Colitis. Theranostics, 12, 5596-5614.
https://doi.org/10.7150/thno.73650
[20]  Zhu, Z., Luo, Y., Lin, L., Gao, T., Yang, Q., Fan, Y., et al. (2024) Modulating Effects of Turmeric Polysaccharides on Immune Response and Gut Microbiota in Cyclophosphamide-Treated Mice. Journal of Agricultural and Food Chemistry, 72, 3469-3482.
https://doi.org/10.1021/acs.jafc.3c05590
[21]  李柏. 姜黄素通过miRNA-491/PEG10对结直肠癌细胞系HCT116增殖及凋亡作用机制的研究[D]: [博士学位论文]. 长春: 吉林大学, 2020.
[22]  曹文, 周小青. 三七皂苷和丹参酮IIA对炎症相关性结直肠癌小鼠的保护作用及对COX-2蛋白表达的抑制作用[J]. 数字中医药(英文版), 2021, 4(1): 54-63.
[23]  Li, X., Yuan, D., Liu, Y., Zhu, L., Qin, H., Yang, Y., et al. (2022) Panax Notoginseng Saponins Prevent Colitis-Associated Colorectal Cancer via Inhibition IDO1 Mediated Immune Regulation. Chinese Journal of Natural Medicines, 20, 258-269.
https://doi.org/10.1016/s1875-5364(22)60179-1
[24]  Focaccetti, C., Palumbo, C., Benvenuto, M., Carrano, R., Melaiu, O., Nardozi, D., et al. (2023) The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival. International Journal of Molecular Sciences, 25, Article 232.
https://doi.org/10.3390/ijms25010232
[25]  Ren, B., Kwah, M.X., Liu, C., Ma, Z., Shanmugam, M.K., Ding, L., et al. (2021) Resveratrol for Cancer Therapy: Challenges and Future Perspectives. Cancer Letters, 515, 63-72.
https://doi.org/10.1016/j.canlet.2021.05.001
[26]  严梅娣, 岑雪英. 姜黄素对甲状腺癌细胞SW579增殖和凋亡的影响[J]. 中华全科医学, 2015, 13(3): 396-398+401.
[27]  李婧伊, 王杰, 王瑞. 姜黄素口服纳米乳的制备及其在原位结直肠癌中的应用[J]. 中国医药工业杂志, 2023, 54(4): 554-561+576.
[28]  Hsu, K., Ho, C. and Pan, M. (2023) The Therapeutic Potential of Curcumin and Its Related Substances in Turmeric: From Raw Material Selection to Application Strategies. Journal of Food and Drug Analysis, 31, 194-211.
https://doi.org/10.38212/2224-6614.3454
[29]  王园园. 脱细胞基质水凝胶释放富含姜黄素的外泌体治疗心肌梗死的研究[D]: [硕士学位论文]. 苏州 : 苏州大学, 2023.
[30]  杨娟. 抗TfR抗体偶联物靶向抗瘤效应及其杂交瘤细胞株轻链基因分析[D]: [博士学位论文]. 武汉: 华中科技大学, 2011.
[31]  Scazzocchio, B., Minghetti, L. and D’Archivio, M. (2020) Interaction between Gut Microbiota and Curcumin: A New Key of Understanding for the Health Effects of Curcumin. Nutrients, 12, Article 2499.
https://doi.org/10.3390/nu12092499

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133